Dr. Agarwal's Health Care Limited (NSE:AGARWALEYE)

Market Cap	142.66B +16.8%
Revenue (ttm)	19.76B +23.5%
Net Income	1.26B +40.6%
EPS	3.96 +28.5%
Shares Out	316.96M
PE Ratio	113.53
Forward PE	85.54
Dividend	n/a
Ex-Dividend Date	n/a

Volume	44,530
Average Volume	82,187
Open	444.95
Previous Close	446.25
Day's Range	442.30 - 452.20
52-Week Range	327.00 - 568.00
Beta	n/a
RSI	52.19
Earnings Date	May 21, 2026

About Dr. Agarwal's Health Care

Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the tr...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2010
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AGARWALEYE

Financial Performance

In fiscal year 2025, Dr. Agarwal's Health Care's revenue was 17.11 billion, an increase of 28.44% compared to the previous year's 13.32 billion. Earnings were 834.60 million, an increase of 0.48%.